JP6144686B2 - β−C−アリールグルコシドの調製方法 - Google Patents

β−C−アリールグルコシドの調製方法 Download PDF

Info

Publication number
JP6144686B2
JP6144686B2 JP2014539427A JP2014539427A JP6144686B2 JP 6144686 B2 JP6144686 B2 JP 6144686B2 JP 2014539427 A JP2014539427 A JP 2014539427A JP 2014539427 A JP2014539427 A JP 2014539427A JP 6144686 B2 JP6144686 B2 JP 6144686B2
Authority
JP
Japan
Prior art keywords
formula
compound
aryl
group
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2014539427A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014532690A (ja
Inventor
ヘンチキ,ジュリアン・ポール
リン,チェン−ウェイ
ウー−ピン・ユー
シャオ,チ−ヌン
リャオ,ジー−シュン
シャオ,ツン−ユー
Original Assignee
サイノファーム・タイワン・リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by サイノファーム・タイワン・リミテッド filed Critical サイノファーム・タイワン・リミテッド
Publication of JP2014532690A publication Critical patent/JP2014532690A/ja
Application granted granted Critical
Publication of JP6144686B2 publication Critical patent/JP6144686B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP2014539427A 2011-11-07 2012-11-07 β−C−アリールグルコシドの調製方法 Expired - Fee Related JP6144686B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161556780P 2011-11-07 2011-11-07
US61/556,780 2011-11-07
US201261661793P 2012-06-19 2012-06-19
US61/661,793 2012-06-19
PCT/IB2012/002894 WO2013068850A2 (en) 2011-11-07 2012-11-07 PROCESS FOR THE PREPARATION OF β-C-ARYL GLUCOSIDES

Publications (2)

Publication Number Publication Date
JP2014532690A JP2014532690A (ja) 2014-12-08
JP6144686B2 true JP6144686B2 (ja) 2017-06-07

Family

ID=48290709

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014539427A Expired - Fee Related JP6144686B2 (ja) 2011-11-07 2012-11-07 β−C−アリールグルコシドの調製方法

Country Status (11)

Country Link
EP (1) EP2776449B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP6144686B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR101756772B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN103974964B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU2012335280B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BR112014010997A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2854591A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL232418A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN (1) IN2014CN04050A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TWI488861B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO2013068850A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104557894A (zh) * 2013-10-18 2015-04-29 上海信谊药厂有限公司 坎格列汀晶型及其制备方法
US9328100B2 (en) * 2014-04-11 2016-05-03 Scinopharm Taiwan, Ltd. Process for the preparation of β-C-arylglucosides
CN105017237A (zh) * 2014-04-29 2015-11-04 嘉实(湖南)医药科技有限公司 一种卡格列净的制备工艺
EP2947077A1 (en) 2014-05-19 2015-11-25 LEK Pharmaceuticals d.d. Stereoselective synthesis of intermediates in the preparation of ß-C-arylglucosides
US10370365B2 (en) 2015-09-16 2019-08-06 Optimus Drugs (P) Limited Process for the preparation of Canagliflozin
CN105294624B (zh) * 2015-11-16 2018-01-12 山东罗欣药业集团股份有限公司 一种达格列净的制备方法
CN105486767B (zh) * 2015-12-03 2018-03-13 上海应用技术学院 一种达格列净及其α‑异构体的分离方法
CN105541815B (zh) * 2015-12-24 2018-07-13 寿光富康制药有限公司 一种卡格列净的制备方法
WO2021176096A1 (en) 2020-03-05 2021-09-10 Krka, D.D., Novo Mesto Pharmaceutical composition comprising sglt2 inhibitor
EP4161912A1 (en) 2020-06-05 2023-04-12 KRKA, d.d., Novo mesto Preparation of highly pure amorphous dapagliflozin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5872599A (ja) * 1981-10-27 1983-04-30 Kanto Ishi Pharma Co Ltd 複合糖質誘導体
EP1581543A4 (en) * 2003-01-03 2008-03-19 Bristol Myers Squibb Co METHODS FOR PRODUCING SGLT2 GLYCOSIS C-ARYL INHIBITORS
AR056195A1 (es) * 2005-09-15 2007-09-26 Boehringer Ingelheim Int Procedimientos para preparar derivados de (etinil-bencil)-benceno sustituidos de glucopiranosilo y compuestos intermedios de los mismos
EP2504346A1 (en) 2009-11-24 2012-10-03 South African Medical Research Council Method for the synthesis of aspalathin and analogues thereof

Also Published As

Publication number Publication date
WO2013068850A2 (en) 2013-05-16
AU2012335280A1 (en) 2014-05-22
CN103974964A (zh) 2014-08-06
BR112014010997A2 (pt) 2017-06-06
IN2014CN04050A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2015-07-10
TWI488861B (zh) 2015-06-21
IL232418A (en) 2016-10-31
EP2776449A4 (en) 2015-10-07
WO2013068850A3 (en) 2013-08-22
EP2776449A2 (en) 2014-09-17
CA2854591A1 (en) 2013-05-16
WO2013068850A8 (en) 2013-10-10
KR20140089427A (ko) 2014-07-14
JP2014532690A (ja) 2014-12-08
IL232418A0 (en) 2014-06-30
TW201335175A (zh) 2013-09-01
EP2776449B1 (en) 2017-08-02
AU2012335280B2 (en) 2016-09-29
CN103974964B (zh) 2016-03-23
KR101756772B1 (ko) 2017-07-26

Similar Documents

Publication Publication Date Title
JP6144686B2 (ja) β−C−アリールグルコシドの調製方法
JP4834080B2 (ja) グルコピラノシル置換ベンジル−ベンゼン誘導体の調製方法及びこれらの方法における中間体
US8952139B2 (en) Process for the preparation of β-C-aryl glucosides
CA2775962C (en) Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives
JP6105489B2 (ja) アリールグルコシド化合物、その調製方法及び使用
TW200406193A (en) Azulene derivative and salt thereof
CN101495495A (zh) 取代螺缩酮衍生物、及其作为糖尿病治疗药的应用
CN104496952B (zh) 一种达格列净的合成方法
WO2015181692A1 (en) Process for preparation of canagliflozin
CN101475615B (zh) 氨基酸糖类化合物及其用途
CN102241721A (zh) 一种卡培他滨及其羟基衍生物中间体的制备方法
EP4249462A1 (en) Method for producing ketone derivative
CN109111490A (zh) 卤代新戊酰基吡喃葡萄糖及其用于sglt2抑制剂的制备方法
CN110041377B (zh) 一种o-甘露聚糖核心结构的合成方法
CN106565800B (zh) 三糖对甲氧基苯酚苷类化合物及其制备方法
WO2006088256A1 (ja) 1,2−トランスグリコシド化合物の製造方法
CN104945363B (zh) 一种制备3‑脱氧苯基c‑糖苷类sglt2抑制剂的制备方法及其中间体
Peng et al. Synthesis, Isolation, Characterization and Suppression of Impurities during Optimization of Empagliflozin (Jardiance)
CN105732555B (zh) 一种合成3-氧代糖苷类sglt2抑制剂的方法
CN117720542A (zh) 一种瑞德西韦中间体gs-441524的制备方法
Mičová et al. Some amino sugars structurally related to 6-deoxymannojirimycin precursors prepared from methyl 6-deoxy-2, 3-O-isopropylidene-α-d-lyxo-hexofuranosid-5-ulose and methyl 2, 3-O-isopropylidene-α-d-lyxo-pentodialdo-1, 4-furanoside
Delft Synthetic studies towards oligonucleotide derivatives and conjugates
Zeng Development of novel strategies based on Lewis acid and transition metal mediated stereoselective c-glycosylation
HK1130063A (en) Substituted spiroketal derivative and use thereof as drug for treating diabetes
CN104418847A (zh) 4-(6-脱氧-β-D-吡喃葡萄糖基)-2-[5-(4-氟苯基)噻吩-2-甲基]-1-甲基苯的制备工艺

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150330

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150626

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20151225

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160421

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20160530

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20160805

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170328

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20170511

R150 Certificate of patent or registration of utility model

Ref document number: 6144686

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees